
Apellis Pharma (APLS) Latest News & Updates
Explore latest Apellis Pharma (APLS) News and Updates
Stay updated on Apellis Pharma (APLS) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Apellis Pharma (APLS)
Order type
Buy in
Order amount
Est. shares
0 shares
GlobeNewsWire •


Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •


InvestorPlace •

Zacks Investment Research •

The Motley Fool •

GlobeNewsWire •

Seeking Alpha •

Seeking Alpha •

Zacks Investment Research •


The Motley Fool •

Investors Business Daily •


24/7 Wall Street •


Zacks Investment Research •

The Motley Fool •

GlobeNewsWire •


The Motley Fool •

GlobeNewsWire •
